[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@BIOTECHSCANNER Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1408278003109466115.png) @BIOTECHSCANNER BIOTECH SCANNER

BIOTECH SCANNER posts on X about $iova, $nklr, $gsrt, $aqst the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

### Engagements: XXXXX [#](/creator/twitter::1408278003109466115/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1408278003109466115/c:line/m:interactions.svg)

- X Week XXXXXX -XX%
- X Month XXXXXXX +211%
- X Months XXXXXXX -XX%
- X Year XXXXXXXXX +6.30%

### Mentions: XX [#](/creator/twitter::1408278003109466115/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1408278003109466115/c:line/m:posts_active.svg)

- X Week XXX +58%
- X Month XXX +277%
- X Months XXX -XX%
- X Year XXXXX +48%

### Followers: XXXXX [#](/creator/twitter::1408278003109466115/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1408278003109466115/c:line/m:followers.svg)

- X Week XXXXX +0.62%
- X Month XXXXX +2.40%
- X Months XXXXX +7.10%
- X Year XXXXX +26%

### CreatorRank: XXXXXXX [#](/creator/twitter::1408278003109466115/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1408278003109466115/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1408278003109466115/influence)
---

**Social category influence**
[finance](/list/finance)  XXXX% [stocks](/list/stocks)  XXXX% [countries](/list/countries)  XXXX% [technology brands](/list/technology-brands)  XXXX% [cryptocurrencies](/list/cryptocurrencies)  XXXX% [vc firms](/list/vc-firms)  XXXX% [currencies](/list/currencies)  XXXX%

**Social topic influence**
[$iova](/topic/$iova) #1, [$nklr](/topic/$nklr) #11, [$gsrt](/topic/$gsrt) #11, [$aqst](/topic/$aqst) #4, [ticker](/topic/ticker) #490, [$fro](/topic/$fro) #167, [mckesson](/topic/mckesson) #9, [future of](/topic/future-of) 0.86%, [the only](/topic/the-only) 0.57%, [patience](/topic/patience) XXXX%

**Top accounts mentioned or mentioned by**
[@therealdansfera](/creator/undefined) [@cricket99238](/creator/undefined) [@america4life72](/creator/undefined) [@henry431171040](/creator/undefined) [@marketmacher](/creator/undefined) [@bambossie81](/creator/undefined) [@abdulla42356398](/creator/undefined) [@fire_truck5](/creator/undefined) [@songkt80](/creator/undefined) [@the_cheeb](/creator/undefined) [@rosenzweigdmd](/creator/undefined) [@mhelvz12](/creator/undefined) [@harpa70278288](/creator/undefined) [@alexanderjgallo](/creator/undefined) [@hkd_tweets](/creator/undefined) [@biotechxguru](/creator/undefined) [@willmstraya](/creator/undefined) [@ivobeats](/creator/undefined) [@logannyse](/creator/undefined) [@thecheeb](/creator/undefined)

**Top assets mentioned**
[Iovance Biotherapeutics, Inc. Common Stock (IOVA)](/topic/$iova) [Frontline Ltd. (FRO)](/topic/$fro) [McKesson Corporation (MCK)](/topic/mckesson) [Palantir (PLTR)](/topic/$pltr) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [NVIDIA Corp. (NVDA)](/topic/$nvda) [Robinhood Markets, Inc. (HOOD)](/topic/$hood) [Auroracoin (AUR)](/topic/$aur) [Rocket Lab USA, Inc. Common Stock (RKLB)](/topic/$rklb) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [AstraZeneca PLC (AZN)](/topic/$azn)
### Top Social Posts [#](/creator/twitter::1408278003109466115/posts)
---
Top posts by engagements in the last XX hours

"Its $560K now. Was raised in April. Proleukin is $60-100K depending the patient weight. Key Opinion Leaders (KOLs) are telling everyone to start Amtagvi as soon as frontline treatments failed. Its coming together. Thanks for your contribution to the community by providing good information"  
[X Link](https://x.com/BIOTECHSCANNER/status/1978879310498021793) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-16T17:42Z 7508 followers, XX engagements


"$IOVA - Bought the book This is the story of a stage X melanoma survivor who was the LAST patient admitted in the trial for Amtagvi in 2020. He joined our podcast yesterday with @TheRealDanSfera . Dan already bought the book. I already know the story but cant wait to read the book TIL therapy IS THE FUTURE of cancer treatment Why do you think many oncologists incorrectly using Amtagvi as the last line of defense instead of using it sooner Because theres NOTHING else behind Amtagvi. I believe the new mindset coming from key opinion leaders in oncology is recognizing the true benefits of"  
[X Link](https://x.com/BIOTECHSCANNER/status/1973415796782080075) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-01T15:52Z 7508 followers, 3866 engagements


"$GSRT $IOVA $AQST - There is one message I post more often than anything else that I put out there. That is PATIENCE I pounded the table on these companies and provided in depth DD. They all will have their own run at some point. I dont know when the run up will come but the only thing I do consistently is to add on dips. If there is a secret recipe to success it is that Be patient and add on dips. Do this only after your conviction is backed by your research"  
[X Link](https://x.com/BIOTECHSCANNER/status/1975263411316699260) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-06T18:14Z 7506 followers, 3363 engagements


"$IOVA - Look at how amazing Amtagvi is doing outside of clinical trials and in the real world. Many physicians believe clinical trials are rigged in favor of the drug. But this isnt a clinical trial. These are results compiled from patients who have been treated with Amtagvi and followed them for X years Remember these patients were planning their funerals my friends. Look at what happens to the tumor burden (how much cancer is still in the body). X weeks after Amtagvi treatment and bam Where did it go I have been in the pharmaceutical industry for XX years. I have never seen a company with a"  
[X Link](https://x.com/BIOTECHSCANNER/status/1978232940116287820) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-14T22:54Z 7509 followers, 3481 engagements


"@RosenzweigDMD Remember this name: InspiroGene by McKesson. This partnership is a game changer. I will discuss more. We dont need a miracle. We just want to see progress. I think we will"  
[X Link](https://x.com/BIOTECHSCANNER/status/1978278956399776239) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-15T01:57Z 7504 followers, XXX engagements


"$IOVA $AQST $NKLR You k know what people were saying about $PLTR a couple of years ago when the share price was around $X at the beginning of January 2023 X. They are losing money like crazy X. They are diluting. X. Business not growing X. Business model is too complicated X. What the hell do they do These are the same people who quietly loaded while saying these things. $PLTR is trading at $XXX today. Shorts want you to expect current revenue from $PLTR but should only be paying $X per share. They do this EVERYDAY. They are everywhere. These are the people who tell you that you can enjoy the"  
[X Link](https://x.com/BIOTECHSCANNER/status/1977762311118229805) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-13T15:44Z 7504 followers, 3482 engagements


"$IOVA $AQST - These have nothing to do with tariffs by the way 😀"  
[X Link](https://x.com/BIOTECHSCANNER/status/1976687125786776056) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-10T16:31Z 7502 followers, 2583 engagements


"$IOVA - What does Amtagvi say to tumor burden Where are you now @IovanceBio"  
[X Link](https://x.com/BIOTECHSCANNER/status/1978287464235045027) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-15T02:31Z 7509 followers, 3452 engagements


"@Cricket99238 Even if I didnt invest in $IOVA I would still wholeheartedly rooting for it to succeed. Who wouldnt Since I am an investor its even easier for me to support its causes 😀. Its going to be fun here soon"  
[X Link](https://x.com/BIOTECHSCANNER/status/1977841229238071320) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-13T20:57Z 7505 followers, XXX engagements


"$IOVA - Chemotherapy combos in second line NSCLC get about X% ORR. They are pathetic. You want to talk about a low bar and the extremely high unmet need in this population Society desperately needs Amtagvi to get approved ASAP if the ORR is XX% or above and DOR is X months or above. 125K deaths in the US and XXX million deaths globally per year. And its only gotten worse Data from 2023 already showing ORR XXXX% (6/23); DOR XX% of confirmed responders had responses lasting X months. Disease Control Rate (DCR) 82.6%. We are getting data sometime in the next X months. Trust me when I say this:"  
[X Link](https://x.com/BIOTECHSCANNER/status/1978217384407175528) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-14T21:52Z 7509 followers, 2667 engagements


"$IOVA - I will be using this checklist for $IOVA during the podcast today. This is pinned on my profile. There are quite a few potential investors in $IOVA so I have to kind of going back over the fundamentals. X. Undervalued (low market cap vs assets and market potential)✅ X. Solid management (biotech experience CEO track record and reputation not too many turnovers)✅ X. Great pipeline versus whats currently available (look for first and only or best in class potential.✅ X. Solving a big unmet need ✅ X. Incremental successes through various stages of clinical trials ✅ X. Strong upcoming"  
[X Link](https://x.com/BIOTECHSCANNER/status/1978594899252420859) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-15T22:52Z 7510 followers, 2824 engagements


"Im going to continue to share your story Chris. On February XX 2024 I tweeted an interview that you did with someone. About XX minutes later the PR from $IOVA announcing approval of Amtagvi. I have been tell people that it doesnt matter if they are investing in Iovance or not they should support the company because someday they or someone they know may need TIL treatment from Iovance. I appreciate you continuing to share your miraculous story. I look forward to seeing you on @TheRealDanSfera podcast hopefully after you get back from NYC"  
[X Link](https://x.com/BIOTECHSCANNER/status/1978306232701112468) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-15T03:45Z 7505 followers, XXX engagements


"$IOVA - The most important pioneer in tumor-infiltrating lymphocyte (TIL) therapy for cancer. Its come a long way. Thanks to Dr. Steven Rosenberg at the National Cancer Institute (NCI) who came up with the original idea of TIL therapy. The company was founded in 2007 and originally called Genesis Biopharma Inc. in California with the initial focus on developing personalized cell therapies for solid tumors using TIL (tumor-infiltrating lymphocytes) technology. As previously stated the TIL concept came from work at the U.S. National Cancer Institute (NCI) under Dr. Steven Rosenberg a pioneer in"  
[X Link](https://x.com/BIOTECHSCANNER/status/1977507643079180417) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-12T22:52Z 7504 followers, 3348 engagements


"$AQST - Dead On Arrival (DOA) will be the final destination of this new option along with Neffy. Belhaven Biopharma will become BelHELL Biopharma. The company is missing the point. Get rid of the device The only way to do that is using the film- Anaphylm The only way to increase the carry curve is to not have a bulky device. This is a bad idea"  
[X Link](https://x.com/BIOTECHSCANNER/status/1976482401103515740) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-10T02:58Z 7501 followers, 2531 engagements


"$GSRT - By the way this is now my biggest position in the portfolio. Even bigger than $IOVA and I have a lot there. $AQST is in third place. This is the new three headed monster. To a bright future 🚀. Patience 🤑. I cant wait to see $NKLR on the list. Love the ticker symbol"  
[X Link](https://x.com/BIOTECHSCANNER/status/1972766846526111919) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-09-29T20:54Z 7500 followers, 3737 engagements


"$IOVA - So apparently I know what I was talking about when I said the partnership with InspiroGene by McKesson is a game changer. XX years of pharmaceutical experience 🐉. Thats what you get from me. Free"  
[X Link](https://x.com/BIOTECHSCANNER/status/1978465975600087325) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-15T14:20Z 7509 followers, 2549 engagements


"$IOVA - Did you know Genesis merged with Lion and later became a dragon (adopted by the 🐉 family) named Iovance. The name reflects its vision to focus on the advancement of immuno-oncology (I/O + advance). Remember the name Lion. Now you know. 😀"  
[X Link](https://x.com/BIOTECHSCANNER/status/1977388282582356349) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-12T14:57Z 7502 followers, 2303 engagements


"$IOVA - The most undervalued company in biotech by a mile. I have warned shorts Q4 is basically here. Their days are numbered. Insiders dont randomly buy shares with their own money. They already have so many free ones. But they bought With X sets of data coming and you and I know that they know whats up. Q4 will be 🔥"  
[X Link](https://x.com/BIOTECHSCANNER/status/1972761180176286050) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-09-29T20:31Z 7509 followers, 4268 engagements


"$AQST $GSRT (NKLR) $IOVA - I love our🐉family and I made the promise since I started this community that I would never turn this into a paid service. NEVER. I dont want to turn family members into customers even though many have recommended to take my DD to other platforms and making it private so I dont take shots from trolls. For every troll there are XX awesome 🐉 members so its not a big deal. The only thing that I have requested from this community is that if you are making profits from my ideas and DD that you would kindly donate a tiny bit of that to . This is the hospital that treats"  
[X Link](https://x.com/BIOTECHSCANNER/status/1974495325629948171) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-04T15:22Z 7504 followers, 4255 engagements


"$IOVA - I have more DD coming Monday. Very exciting for the future of Iovance Biotherapeutics. The new FDA is perfect for $IOVA right now. Oh my book just arrived"  
[X Link](https://x.com/BIOTECHSCANNER/status/1974237187987083702) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-03T22:16Z 7501 followers, 2629 engagements


"$IOVA - There is no name that is bigger than McKesson in healthcare services and distribution. It distributes pharmaceuticals medical-surgical supplies and provides healthcare technology solutions. By partnering with InspiroGene by McKesson more patients can get Amtagvi. This is a massive game changer. If there is one thing I know well about the pharmaceutical industry this is it No matter how good the drug is if the insurance approval process is too complicated the prescription will not be filled InspiroGene will leverage Biologics by McKessons more than XX years of specialty pharmacy and"  
[X Link](https://x.com/BIOTECHSCANNER/status/1978282354767503744) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-15T02:10Z 7509 followers, 2681 engagements


"$IOVA - I have been doing DD all day with new materials that I found and will share with you Monday morning. I am taking a quick break to tell you that NONE OF US HAS ENOUGH SHARES. I truly believe that this ticker is headed towards the teens levels again by the end of this year"  
[X Link](https://x.com/BIOTECHSCANNER/status/1974629548785283125) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-05T00:15Z 7510 followers, 4669 engagements


"$IOVA - Earlier today I posted about the hiring of former FDA leaders Dr. Raj Puri and Dr. Marc Theoret to Iovance Biotherapeutics to focus on Regulatory Strategy.This is a very smart move. Currently they have an amazing working relationship with the FDA. As a matter of fact EVERY TRIAL DESIGNS is done with the FDA and in the case of the Frontline Melanoma and confirmatory trial in 2L melanoma for Amtagvi TILVANCE XXX also with the European Medicines Agency (EMA). This was discussed during the Wells Fargo conference with CFO Corleen Roche and EVP Brian Gastman MD at minute XX. I highly"  
[X Link](https://x.com/BIOTECHSCANNER/status/1976450785773838647) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-10T00:52Z 7502 followers, 3012 engagements


"$IOVA - What is The National Comprehensive Cancer Network (NCCN) It is a nonprofit alliance of XX leading U.S. cancer centers including MD Anderson Memorial Sloan Kettering and Dana-Farber that develops widely used clinical practice guidelines for cancer care. NCCNs main work is creating and maintaining evidence-based treatment guidelines for almost every cancer type.These guidelines are used by oncologists insurers and regulatory agencies to decide: X. What the standard of care treatments are. X. When a therapy is appropriate (first line second line etc.) a. How to sequence therapies b. How"  
[X Link](https://x.com/BIOTECHSCANNER/status/1978129549348012329) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-14T16:03Z 7509 followers, 2796 engagements


"@Cricket99238 $VKTX was my very first release in December 2023 Released it under $XX and it got to $XXXXX about X months later Thats my specialty. I launched Ozempic with Novo Nordisk"  
[X Link](https://x.com/BIOTECHSCANNER/status/1979032239187910774) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-17T03:50Z 7510 followers, XXX engagements


"$IOVA - Let me introduce you to Brian Gastman M.D. Executive Vice President Medical Affairs. Look at his experience and qualifications. Iovance has built an amazing team with exceptional expertise in their respective fields. He joined $IOVA because he believes in the future of TIL therapy and rightly so I love this part: Dr. Gastman founded and currently leads the Society of Immunotherapy of Cancer (SITC)s Surgery Committee. SITC is one of the premier cancer society in the world Listen to his interview from X months ago on the Beyond Biotech podcast and judge for yourself. $IOVA is in great"  
[X Link](https://x.com/BIOTECHSCANNER/status/1975188805960233202) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-06T13:18Z 7504 followers, 2705 engagements


"$IOVA - Anne Brooks will be in Philadelphia to participate in Keynote Panel Discussion: State of the Industry Address for Cell and Gene Therapies on November XX. This is what happens when you are the leader in cell therapy. People want to know and learn from you the good and the bad. $IOVA revenue increased XX% from Q1 to Q2. This is the type of progress that we want to see. I expect similar or better growth in Q3 with higher margins. The community hospitals becoming their own ATCs (Authorized Treatment Centers) is a huge deal for several reasons: X. The patients at community hospitals are"  
[X Link](https://x.com/BIOTECHSCANNER/status/1977748458254598197) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-13T14:49Z 7502 followers, 2584 engagements


"$IOVA - EVP Medical Affairs Brian Gastman MD was asked about interactions with the FDA said the communications have been constant. Our CROChief Regulatory Officer Dr. Raj Puri MD who is an expert on checkpoint inhibitors and cell therapy hired a lot of the people who are making the decisions (at FDA) right now. I believe if the final data for second line NSCLC is positive management is going to push the FDA to give them the new voucher for a X month decision timeline instead of the typical six to XX months. The National Voucher is meant for rare and deadly diseases but the FDA also has the"  
[X Link](https://x.com/BIOTECHSCANNER/status/1976749041389031785) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-10T20:37Z 7502 followers, 2326 engagements


"$IOVA - Just added more for my wifes account. My daughters account has quite a few shares as well now. Any divorce lawyers in 🐉 family 😂. Unbelievably cheap at this price"  
[X Link](https://x.com/BIOTECHSCANNER/status/1976714622700040350) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-10T18:21Z 7510 followers, 2974 engagements


"$GSRT - As expected the merger is approved. I am still waiting on when the official ticker change will take place. $NKLR what a name Love this company Will keep you posted"  
[X Link](https://x.com/BIOTECHSCANNER/status/1975931957445115970) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-08T14:31Z 7505 followers, 3632 engagements


"🐉 Family. Its been a while since Ive released a non biotech company. Friday September XX 2025 at 9:30 ET I will release an amazing one. My most recent ones are $NVDA at $XXX before the forward split so $XX split adjusted. $AUR $HOOD and $RKLB are the others. This one will go atomic on us. Full DD coming"  
[X Link](https://x.com/BIOTECHSCANNER/status/1970906075055653084) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-09-24T17:40Z 7503 followers, 2567 engagements


"@dan_glinert $IOVA - Iovance will have Merck AstraZeneca and BMY drooling soon. The NSCLC market is so big"  
[X Link](https://x.com/BIOTECHSCANNER/status/1976754014617571419) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-10T20:57Z 7500 followers, XXX engagements


"$IOVA - @Merck Your Iovance Biotherapeutics and you can team up to defeat solid cancers like in the Frontline metastatic melanoma study TILVANCE XXX right now. You dont have to look very far. If not AstraZeneca will. @IovanceBio"  
[X Link](https://x.com/BIOTECHSCANNER/status/1979281186825335067) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-17T20:19Z 7510 followers, XXX engagements


"$IOVA - Abivax $ABVX with a current market cap at around $7B was trading at $XX on July XX 2025. Then after hours a PR arrived with this headline: Abivax Announces Positive Phase X Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod its First-in-Class Oral miR-124 Enhancer in Moderate to Severely Active Ulcerative Colitis The next day July XX 2025 it rose to $XXXXX. We are waiting on not X not X but X separate clinical trials data on NSCLC endometrial cancer and melanoma. The total addressable market for just NSCLC alone is already much higher than ulcerative colitis So"  
[X Link](https://x.com/BIOTECHSCANNER/status/1977911939033358423) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-14T01:38Z 7509 followers, 5643 engagements


"$AQST $IOVA $GSRT - This is a humbling post and I appreciate the kind words from a 🐉 family member. Its not easy I can tell you especially when several people turned against me JUST BECAUSE THE SHARE PRICE DROPPED. Not anything else. This is what happens when they dont do research and totally put the responsibility on me for their investments. Oh did they missed out on this opportunity and look foolish in the process. Patience is a virtue and so as kindness. Thank you @NLeounakis"  
[X Link](https://x.com/BIOTECHSCANNER/status/1976345237292212254) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-09T17:53Z 7506 followers, 2858 engagements


"$GSRT - Tomorrow is the voting day on the merger. After the merger is closed the ticker will change to $NKLR"  
[X Link](https://x.com/BIOTECHSCANNER/status/1975194375144788296) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-06T13:40Z 7505 followers, 2649 engagements


"$IOVA - What makes Amtagvi unique Why can it destroy cancer cells in solid tumors that CAR-T cant Because the T-cells in Amtagvi are REACTIVE T-cells. Whats that mean TIL (Tumor Infiltrating Lymphocytes) are harvested from at least a 1.5cm of tumor tissue. These lymphocytes already infiltrated or entered the tumor and fighting in the tumor micro environment. These lymphocytes already REACTED or RECOGNIZED the cancer cells whereas in CAR-T the T lymphocytes are collected from the peripheral blood. These T-cells could have been watching Monday Night Football when they were gathered then"  
[X Link](https://x.com/BIOTECHSCANNER/status/1975973162354385399) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-08T17:14Z 7506 followers, 2834 engagements


"$GSRT - Today is voting day for the merger. If approved (100%) the ticker will change to $NKLR after approximately X business days from today. The company will announce the date. You dont have to do anything. However on the day that the ticker change takes effect during premarket your brokerage may show GSRT as delisted so DONT FREAK OUT like shorts will when $IOVA announces positive data for NSCLC(Non-Small Cell Lung Cancer) endometrial cancer and 2L melanoma with IOV-4001 any day now"  
[X Link](https://x.com/BIOTECHSCANNER/status/1975549264634732894) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-07T13:10Z 7505 followers, 3341 engagements


"$NKLR - This will never get old 🤑"  
[X Link](https://x.com/BIOTECHSCANNER/status/1977827800666292673) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-13T20:04Z 7510 followers, 4091 engagements


"@Cricket99238 $IOVA will be at least a $20Bn company. It will actually be bought out before 2026 is over by Merck Bristol Myers or AstraZeneca"  
[X Link](https://x.com/BIOTECHSCANNER/status/1976420083724583048) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-09T22:50Z 7510 followers, XXX engagements


"$IOVA - After hiring one of the big guns at the FDA in Dr. Raj Puri who joined Iovance in March 2022 as Executive Vice President Regulatory Strategy and Translational Medicine. Dr. Puri was promoted to Chief Regulatory Officer on November XX 2024. Then on July XX 2025 $IOVA announced another former FDA leader with the appointment of Marc. R Theoret M.D. to assume the newly created position of Senior Vice President Regulatory Strategy where he will focus on clinical regulatory strategy for Iovances pipeline. Effective immediately Dr. Theoret will report to Dr. Raj K. Puri M.D. Ph.D. Chief"  
[X Link](https://x.com/BIOTECHSCANNER/status/1976357503609995503) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-09T18:42Z 7500 followers, 3356 engagements


"$IOVA $NKLR - If you think $NKLR is explosive just wait until $IOVA releases data coming any day now on NSCLC endometrial cancer and next generation TIL IOV-4001 in second line metastatic melanoma. Current sitting at around $X I believe we may see $10-$12 especially with positive Q3 earnings. I believe theres a XXXX% chance that NSCLC will be positive and the company will use it as part of the accelerated FDA approval. Dont miss this one. I dont miss on data results prediction either"  
[X Link](https://x.com/BIOTECHSCANNER/status/1977849856216686764) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-13T21:32Z 7509 followers, 4129 engagements


"$IOVA - Chris White who wrote Killing Cancer with TILs will be on stage to share his testimony on how Amtagvi saved his life from the brink of death at the GLOBAL CANCER RESEARCH AND INNOVATION SYMPOSIUM on October 21st in NYC on behalf of Alliance for Cancer Gene Therapy. Guess what message hes going to share Hes going to say why did his team of oncologists waited SO LONG to recommend him to the clinical trial in 2020. Hes encouraging physicians to recommend Amtagvi SOONER AND HE IS NOT GETTING PAID BY $IOVA. How powerful is that It has to be about the drug as the starting point to invest in"  
[X Link](https://x.com/BIOTECHSCANNER/status/1976099481977339938) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-09T01:36Z 7502 followers, 2707 engagements


"$GSRT - The company has not announced the ticker change date yet. No rush"  
[X Link](https://x.com/BIOTECHSCANNER/status/1976296843408503133) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-09T14:40Z 7508 followers, 2182 engagements


"$IOVA - How do you think these insiders feel about the up coming data releases for NSCLC endometrial cancer and next generation TIL IOV-4001 Hmm"  
[X Link](https://x.com/BIOTECHSCANNER/status/1976285319931789603) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-09T13:55Z 7501 followers, 3592 engagements


"@SMAC1945 Definitely not. Actually Prasad and Makary make me more bullish on $IOVA. THEY are constantly in communication with the FDA. Many people who are approving cancer drugs right now were hired by Dr. Puri Chief Regulatory Officer at $IOVA"  
[X Link](https://x.com/BIOTECHSCANNER/status/1978257226763579455) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-15T00:30Z 7506 followers, XXX engagements


"$IOVA - You may notice that the company probably will not release ANY clinical trials data at upcoming conferences. This is EXACTLY what we want. Iovance wants to publish data in a peer reviewed journal. It is more expensive and time consuming BUT if they want to destroy shorts this is how to do it. Publish data in peer reviewed journal and send it via PRs through numerous news outlets. Dr. Brian Gastman EVP Medical Affairs talked about how the company is going to be releasing data during the Wells Fargo Healthcare Conference on September X 2025. After releasing data via PRs the company will"  
[X Link](https://x.com/BIOTECHSCANNER/status/1979290785821417867) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-17T20:57Z 7510 followers, 1639 engagements


"@mhelvz12 Nice I definitely believe so. $IOVA will be bought out way before XX years from now. I think X years max"  
[X Link](https://x.com/BIOTECHSCANNER/status/1978259165765095446) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-15T00:38Z 7505 followers, XXX engagements


"$IOVA - The combination of making large community hospitals and the partnership with InspiroGene by McKesson is a game changer. They are a specialty pharmacy that specializes in complicated treatments and get authorization for the patients X. Oncologists now dont have to send patients to another ATC. They can treat them right at the same hospital. X. Oncologists can start patients on Amtagvi as soon as first line treatments fail them. X. Healthier patients respond much better to Amtagvi treatment thus improving their survival chances. Remember these patients run out of options fast after"  
[X Link](https://x.com/BIOTECHSCANNER/status/1975931242781552788) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-08T14:28Z 7508 followers, 2500 engagements


"$AQST- Bong Koh is also another partner from Venrock Healthcare Partners (VHCP) named in the 13G. His bio Better than mine 😂"  
[X Link](https://x.com/BIOTECHSCANNER/status/1775514711674482864) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2024-04-03T13:24Z 7501 followers, 3320 engagements


"$IOVA - This is the order of PRs that I am hoping we will be getting: X. Q3 earnings💥 X. Switzerland approval💥 X. Endometrial cancer data💥 X. IOV 4001 data for melanoma 💥 X. NCSLC data💥 The company has mentioned that they want to let the data matured because of the exceptional durability of the TIL treatment that will favor Duration of Response (DOR). So maybe we will get X sets of data in December. I am completely cool with that. But if Q3 earnings is positive the stage is set for potentially the biggest runner in biotech this year with X catalysts. If you are waiting on X catalyst its"  
[X Link](https://x.com/BIOTECHSCANNER/status/1978200131024343316) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-14T20:43Z 7510 followers, 4347 engagements


"@Storm28799 They will not sell $IOVA for less than $X billion. The longer they wait the more they will have to pay if Amtagvi sales increase and new indications coming like NSCLC"  
[X Link](https://x.com/BIOTECHSCANNER/status/1979194040923877389) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-17T14:33Z 7510 followers, XXX engagements


"$IOVA $AQST $NKLR - External negative sentiments tend to have a piling on effect. When a stock price drops the bears pile on even more. You should know this by now. This is the main reason I dont go on StockTwits. If you want to be an investor with sound mind dont go on ST. Why do I say this Because even if you dont want to admit or thinking it wont affect you it does. The majority of shorts will go on these platforms to scare you. Thats what they do Their existence depends on the stock price dropping They have a huge incentive to create fear uncertainty and doubt Let me share with you my"  
[X Link](https://x.com/BIOTECHSCANNER/status/1977417567707771006) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-12T16:54Z 7503 followers, 3250 engagements


"@biotechreviews Holy moly. Yep I am not surprised. Is there anything better than a new treatment for NSCLC right now Especially when theres none You see why I am saying what I have been saying I am being VERY conservative when I said $10-$12 from current levels for $IOVA. This is biotech"  
[X Link](https://x.com/BIOTECHSCANNER/status/1977899718182068255) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-14T00:50Z 7505 followers, XXX engagements


"@RosenzweigDMD Management is now a strength. CFO Corleen Roche doesnt mess around. She immediately throws the previous CFO under the bus because he misguided into a brand new market. Shes correct. $450M to $475M was too aggressive. $IOVA will be in great shape"  
[X Link](https://x.com/BIOTECHSCANNER/status/1977874211302523177) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-13T23:08Z 7505 followers, XXX engagements


"$IOVA - Each day that goes by the timeline is more condensed for these catalysts. There are X sets of data and X events that will be released and occur by year end: X. Non-Small Cell Lung Cancer (NSCLC) - The death rate in the US alone is staggering at 125K per year. Globally its even worse at XXX million per year. No options except chemotherapy and combination with other checkpoint inhibitors that are not effective. The fatality rate is more than XX times higher than melanoma. The patient population is massive. Second line NSCLC indication alone makes $IOVA the envy of the entire cell"  
[X Link](https://x.com/BIOTECHSCANNER/status/1977801485787259113) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-13T18:19Z 7502 followers, 2916 engagements


"$IOVA - The company is set to release updated interim data for Amtagvi in second line (2L) NSCLC for patients who have gotten worse on chemotherapy and anti PD-1 before the year ends. July X 2023 was the cutoff date for the previous preliminary data that was released on July XX 2023. This recent data cut included XX NSCLC patients treated with LN-145. An ORR of XXXX% by RECIST v1.1 (n=6 one complete response and five partial responses) was observed with a disease control rate of 82.6%. While still early on study the median duration of response (DOR) was not reached. The DOR ranged from 1.4+"  
[X Link](https://x.com/BIOTECHSCANNER/status/1976315855874019726) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-09T15:56Z 7502 followers, 2629 engagements


"$GSRT - 🚀💥"  
[X Link](https://x.com/BIOTECHSCANNER/status/1975221546680803508) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-06T15:28Z 7504 followers, 3554 engagements


"$IOVA - What if I told you that theres a person who was treated with lifileucel (AMTAGVI) in 2013 when Iovance Biotherapeutics was still called Lion Biotechnologies by the inventor of TIL (Tumor Infiltrating Lymphocytes) therapy Dr. Steven Rosenberg himself; and XX years later hes still a complete responder (CR) with NO EVIDENCE OF DISEASE (NED) This person is Bill Heyman. He recently was interviewed by another complete responder Chris White on TIL TALKS. If you think Chris Whites story is amazing then youre in for another treat. This story has a very moving moment that involves Dr. Steven"  
[X Link](https://x.com/BIOTECHSCANNER/status/1977557246595715118) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-13T02:09Z 7500 followers, 6810 engagements


"$IOVA - Cell & Gene Therapy is the hottest sector within biotech. Today Bristol Myers Squibb acquired Orbital Therapeutics that has CAR-T assets for autoimmune diseases. I have said it many times I believe Iovance will be acquired at some point by big pharma. Especially if the NSCLC data is positive in second line. I believe the data will be very positive. In frontline NSCLC using Amtagvi and Pembrolizumab (Keytruda) its already shown incredible efficacy and durability. Patience"  
[X Link](https://x.com/BIOTECHSCANNER/status/1976655405641015375) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-10T14:25Z 7509 followers, 3197 engagements


"$GSRT - What a day Tomorrow maybe the day the ticker change will take place. Cant wait to see $NKLR LFG🚀"  
[X Link](https://x.com/BIOTECHSCANNER/status/1976019468209021123) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-08T20:18Z 7508 followers, 2546 engagements


"$IOVA - X companies that may acquire Iovance Biotherapeutics. X. $MRK (Merck) X. $BMY (Bristol Myers) X. $AZN (AstraZeneca) These X have extensive oncology portfolios. $AZN recently has been extremely aggressive to get into cell and gene therapy. $MRK and $BMY have checkpoint inhibitors that would go very well with Amtagvi and future TIL products in $IOVAs pipeline"  
[X Link](https://x.com/BIOTECHSCANNER/status/1972526798186377473) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-09-29T05:00Z 7505 followers, 8460 engagements


"$GSRT - Merger is closed and will trade as $NKLR starting tomorrow"  
[X Link](https://x.com/BIOTECHSCANNER/status/1976369101875659160) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-09T19:28Z 7505 followers, 3957 engagements


"$IOVA - The company plans to release interim data on: X. Second Line NSCLC - If data is positive then they will wait for phase X to end and then apply for accelerated approval. Because this phase X is a pivotal trial. The company is using the same process as second line metastatic melanoma. The frontline NSCLC in combination with Pembrolizumab will have a dual purpose just like TILVANCE XXX that is to serve as a confirmatory for full second line NSCLC and accelerated frontline approval as well. A lot of attention is paid toward this data release because the NSCLC market is more than 6x of"  
[X Link](https://x.com/BIOTECHSCANNER/status/1978456463392530488) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-15T13:42Z 7509 followers, 2507 engagements


"$IOVA - You should report this 🪳 for manipulation. A typical day trader who takes shortcuts instead of doing the hard work like others. X minute they bash next minute they pump. Report this trash. Thanks to the 🐉 for bringing this to my attention"  
[X Link](https://x.com/BIOTECHSCANNER/status/1967995548411244613) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-09-16T16:54Z 7502 followers, 5294 engagements


"$IOVA - Corleen Roche CFO when answering the question of what drew her to Iovance even though she has a long track record at some large companies like Pfizer and Biogen and CG Oncology said I am very excited to be here and tell you all the good things that drew me to Iovance. Number X we cant forget the product is good its on the market and its helping people. Thats the most important thing. I believe the company is in good hands with her. Corleen Roche is very frank and honest. She has launched some big drugs before. Im very impressed by her previous success. Patience 🐉"  
[X Link](https://x.com/BIOTECHSCANNER/status/1976738115663303080) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-10T19:54Z 7509 followers, 2582 engagements


"$IOVA $AQST $NKLR - All X tickers would have been green yesterday if it werent for a post from the President. I cant stress enough that investing is mostly about mental toughness. There are constantly noises around whether from the macro or micro economic environment or from shorts who live in fear especially if a company has multiple catalysts coming like $IOVA. They have to continually create fear and panic. In these moments we have to lean back to our original thesis on the company that we invested in and asking tough questions like we should. Has anything changed that makes us want to"  
[X Link](https://x.com/BIOTECHSCANNER/status/1977062003324616958) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-11T17:21Z 7504 followers, 9571 engagements


"$IOVA - Amtagvi treatment is saving lives and every day the good news is being shared. This ATC (Authorized Treatment Center) has treated over XX patients and is encouraging oncologists to refer patients to them This ATC is in Atlanta Georgia. Thank you @yss4318 for sending this to me. As the saying goes If you build it they will come. $IOVA has an amazing product in Amtagvi. Due to the complicated nature of the treatment the roll out has been slower than anticipated. But the ball is rolling and is picking up momentum. Amtagvi is a tough treatment to receive because cancer is also tough and"  
[X Link](https://x.com/BIOTECHSCANNER/status/1978104073535492261) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-14T14:22Z 7505 followers, 4155 engagements


"$IOVA - Did you know in 2nd Line Metastatic Melanoma Non-Small Cell Lung Cancer (NSCLC) and Endometrial Cancer THERE IS NO EFFECTIVE TREATMENT and patients only have months to live Immune Checkpoint Inhibitors like Keytruda (pembrolizumab) an anti-PD-1 and Yervoy (ipilimumab) a CTLA-4 were initially indicated for second line after chemotherapy and radiation but since had been moved into frontline. Still XX% or more see their cancers progressed or got worse. Now theres only chemo and other drugs combined to help but they are not effective. Then comes badass Amtagvi. In the pivotal phase 2"  
[X Link](https://x.com/BIOTECHSCANNER/status/1976846047226859870) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-11T03:03Z 7504 followers, 3771 engagements


"$IOVA - If interim phase X data for NSCLC being released anytime in Q4 is positive I believe theres almost a XXX% chance that Amtagvi will get the National Priority Review Voucher cutting FDA decision from 6-10 months to 1-2 months after the final data arrives several months later. The innovation of TIL therapys X time treatment and a massive unmet need in second line NSCLC makes perfect sense for the FDA to grant Amtagvi the priority voucher. After this frontline metastic melanoma in combination with Pembrolizumab in TILVANCE XXX is on deck. Then frontline NSCLC in combination with"  
[X Link](https://x.com/BIOTECHSCANNER/status/1979019381179924647) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-17T02:59Z 7510 followers, 2170 engagements


"$IOVA $NKLR $AQST - Guess what Per CNBC Stock futures rebound from Fridays rout after Trump says China situation will all be fine 😂"  
[X Link](https://x.com/BIOTECHSCANNER/status/1977520920244715967) [@BIOTECHSCANNER](/creator/x/BIOTECHSCANNER) 2025-10-12T23:45Z 7501 followers, 4843 engagements